Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

NCT04023396 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
217
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abivax S.A.